Frezzato F - Search Results

1

Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A.

Zonta F, Pagano MA, Trentin L, Tibaldi E, Frezzato F, Trimarco V, Facco M, Zagotto G, Pavan V, Ribaudo G, Bordin L, Semenzato G, Brunati AM. Zonta F, et al. Among authors: frezzato f. Blood. 2015 Jun 11;125(24):3747-55. doi: 10.1182/blood-2014-12-619155. Epub 2015 Apr 30. Blood. 2015. PMID: 25931585 Free article.

2

Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia.

Trentin L, Frasson M, Donella-Deana A, Frezzato F, Pagano MA, Tibaldi E, Gattazzo C, Zambello R, Semenzato G, Brunati AM. Trentin L, et al. Among authors: frezzato f. Blood. 2008 Dec 1;112(12):4665-74. doi: 10.1182/blood-2008-02-139139. Epub 2008 Sep 2. Blood. 2008. PMID: 18768392 Free article.

3

Apoptotic effect of cyclosporin a and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukemia.

Cabrelle A, Maschio N, Carraro S, Frezzato F, Binotto G, Gattazzo C, Miorin M, Agostini C, Zambello R, Pandolfi F, Semenzato G, Trentin L. Cabrelle A, et al. Among authors: frezzato f. J Biol Regul Homeost Agents. 2009 Oct-Dec;23(4):239-50. J Biol Regul Homeost Agents. 2009. PMID: 20003763

4

Endogenous reactive oxygen species content and modulation of tyrosine phosphorylation during sperm capacitation.

Donà G, Fiore C, Tibaldi E, Frezzato F, Andrisani A, Ambrosini G, Fiorentin D, Armanini D, Bordin L, Clari G. Donà G, et al. Among authors: frezzato f. Int J Androl. 2011 Oct;34(5 Pt 1):411-9. doi: 10.1111/j.1365-2605.2010.01097.x. Epub 2010 Aug 2. Int J Androl. 2011. PMID: 20738429

5

Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells.

Tibaldi E, Brunati AM, Zonta F, Frezzato F, Gattazzo C, Zambello R, Gringeri E, Semenzato G, Pagano MA, Trentin L. Tibaldi E, et al. Among authors: frezzato f. Leukemia. 2011 Nov;25(11):1768-81. doi: 10.1038/leu.2011.152. Epub 2011 Jun 24. Leukemia. 2011. PMID: 21701493

6

Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.

Rampazzo E, Bonaldi L, Trentin L, Visco C, Keppel S, Giunco S, Frezzato F, Facco M, Novella E, Giaretta I, Del Bianco P, Semenzato G, De Rossi A. Rampazzo E, et al. Among authors: frezzato f. Haematologica. 2012 Jan;97(1):56-63. doi: 10.3324/haematol.2011.049874. Epub 2011 Sep 20. Haematologica. 2012. PMID: 21933855 Free PMC article.

7

HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen.

Frezzato F, Gattazzo C, Martini V, Trimarco V, Teramo A, Carraro S, Cabrelle A, Ave E, Facco M, Zambello R, Tibaldi E, Brunati AM, Semenzato G, Trentin L. Frezzato F, et al. PLoS One. 2012;7(6):e39902. doi: 10.1371/journal.pone.0039902. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768161 Free PMC article.

8

SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection.

Vidalino L, Doria A, Quarta SM, Crescenzi M, Ruvoletto M, Frezzato F, Trentin L, Turato C, Parolin MC, Ghirardello A, Iaccarino L, Cavalletto L, Chemello L, Gatta A, Pontisso P. Vidalino L, et al. Among authors: frezzato f. Exp Biol Med (Maywood). 2012 Jul;237(7):793-802. doi: 10.1258/ebm.2012.012024. Epub 2012 Jul 24. Exp Biol Med (Maywood). 2012. PMID: 22829702

9

S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis.

Capitani N, Patrussi L, Trentin L, Lucherini OM, Cannizzaro E, Migliaccio E, Frezzato F, Gattazzo C, Forconi F, Pelicci P, Semenzato G, Baldari CT. Capitani N, et al. Among authors: frezzato f. Blood. 2012 Nov 22;120(22):4391-9. doi: 10.1182/blood-2012-04-425959. Epub 2012 Oct 1. Blood. 2012. PMID: 23033271 Free article.

10

Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.

Leanza L, Trentin L, Becker KA, Frezzato F, Zoratti M, Semenzato G, Gulbins E, Szabo I. Leanza L, et al. Among authors: frezzato f. Leukemia. 2013 Aug;27(8):1782-5. doi: 10.1038/leu.2013.56. Epub 2013 Feb 21. Leukemia. 2013. PMID: 23426166 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters